Plasmin Amplifies Inflammation in Psoriasis
Author Information
Author(s): Li Qun, Ke Fang, Zhang Weiwei, Shen Xiaoyan, Xu Qiannan, Wang Hong, Yu Xue-Zhong, Leng Qibin, Wang Honglin
Primary Institution: Shanghai Institute of Immunology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Hypothesis
The role of plasmin converted from plasminogen by plasminogen activators in the pathogenesis of psoriasis has not been investigated.
Conclusion
Plasmin plays an essential role in amplifying psoriasiform skin inflammation in mice, suggesting that targeting the plasmin receptor may have therapeutic potential for psoriasis.
Supporting Evidence
- Plasminogen was diminished in psoriasis, while plasmin levels were increased.
- Annexin II, a receptor for plasmin, was dramatically increased in psoriatic skin.
- Injection of plasmin induced psoriasiform skin inflammation in mice.
Takeaway
This study found that a substance called plasmin makes skin inflammation worse in psoriasis, which could help scientists find new treatments.
Methodology
The study examined the contribution of plasmin to inflammation in psoriasis using mouse models and human samples.
Participant Demographics
Patients with moderate-to-severe chronic plaque psoriasis.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website